Driving Abilities and Wearing-Off in Parkinson's Disease: A Driving Simulation Study.

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Background/objectivesDriving abilities require the synchronized activity of cerebral networks associated with sensorimotor integration, motricity, and executive functions. Drivers with Parkinson's disease (DwP) have impaired driving ability, but little is known about the impact of "wearing-off" and therapies in addition to L-DOPA on driving capacities. This study aimed to (i) compare driving performance between DwP during different motor states and healthy controls and (ii) assess the impact of add-on therapies on driving abilities.MethodsDwP (n = 26) were enrolled as individuals experiencing wearing-off symptoms and treated (within 6 months before the enrollment) with add-on therapies to L-DOPA, including MAO inhibitors for DwP-A (n = 12) or opicapone for DwP-B (n = 14). Age- and sex-matched controls (CON, n = 12) were also enrolled. DwP received two driving assessments in a driving simulator during their "best-on" time and during their wearing-off time on different days. An anamnestic driving questionnaire was collected with the assistance of partners. A Virtual Driving Rating Scale (VDRS) was calculated, as well as learning curves (LCs) for driving items calculated in minutes.ResultsDwP reported worse driving performance than CON at the driving questionnaire. In line with this, DwP showed worse VDRS (p p = 0.021) than CON. Lower VDRS was associated with wearing-off (p p = 0.037) and more items improving with LCs (7 vs. 3) than DwP-A.ConclusionsDwP demonstrated impaired driving compared to controls. Wearing-off symptoms can also affect driving ability, but therapies (opicapone more so than MAO inhibitors) may play a role in preserving specific driving skills, possibly through maintaining learning abilities.

Related topics